ACT Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
ACT Advisors's MDT Position: Q3 2022 in Review
ACT Advisors sold out of Medtronic (MDT) in Q3 2022, closing a stake of 3,499 shares — an estimated $314K sold.
ACT Advisors first reported a position in MDT in Q4 2020 and held it in 7 quarters. The position peaked at $565K in Q1 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- ACT Advisors reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
- ACT Advisors sold 3,499 Medtronic shares in Q3 2022, an estimated $314K.
- ACT Advisors first reported a position in Medtronic in Q4 2020 and held it in 7 quarters.
- ACT Advisors's Medtronic position peaked at $565K in Q1 2021.
- 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on ACT Advisors's 13F filing for Q3 2022, filed 6 Oct 2022.